Stocktoria
Nautilus Biotechnology, Inc. NAUT
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2020-08-07
Nautilus Biotechnology, Inc. statistics & valuation
Market cap$254.2M
P / B1.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -30.9% | -29.2% | -20.8% | -16.5% | -12.6% |
| Return on equity | -37.6% | -33.9% | -24.0% | -18.4% | -13.8% |
| Current ratio | 13.33 | 17.40 | 19.39 | 27.57 | 60.09 |
Source: SEC EDGAR filings · CIK 0001808805 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.